Five analytics firms launch RWE lobbying group to press Congress, FDA on guidance, Cures 2.0
With around 75% of all new drug approvals in 2020 including real world evidence in their submissions to FDA, data and analytics firms Aetion, Flatiron …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
